世界のケロイド治療市場 2019年

【英語タイトル】Global Keloid Treatment Market Professional Survey Report 2019

QYResearchが出版した調査資料(QYR20FB00794)・商品コード:QYR20FB00794
・発行会社(調査会社):QYResearch
・発行日:2019年11月(※2024年版があります。お問い合わせください)
・ページ数:102
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,500 ⇒換算¥518,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,250 ⇒換算¥777,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,000 ⇒換算¥1,036,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
※本調査レポートは、ケロイド治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、閉塞包帯、圧迫療法、凍結手術、切除、放射線療法、レーザー療法、インターフェロン療法、病巣内コルチコステロイド注射、その他に、用途別には、病院、皮膚科、外来手術センター、その他にセグメント区分し、ケロイド治療の世界市場を分析しました。


・エグゼクティブ・サマリー
・ケロイド治療の世界市場概要
・ケロイド治療の製造コスト構成分析
・ケロイド治療の開発・製造工場分析
・主要メーカーの主な指標(生産能力、売上、価格分析)
・ケロイド治療の地域別分析(生産、売上、主要メーカー、輸出・輸入)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・ケロイド治療のセグメント分析(種類別)
(閉塞包帯、圧迫療法、凍結手術、切除、放射線療法、レーザー療法、インターフェロン療法、病巣内コルチコステロイド注射、その他)
・ケロイド治療のセグメント分析(用途別)
(病院、皮膚科、外来手術センター、その他)
・ケロイド治療の主要メーカー別分析(生産拠点、製品概要、生産・売上実績)
(Novartis、Sensus、RXi、Sonoma、Perrigo、Bristol-Myers Squibb、Pacific World、Valeant、Revitol、Avita)
・ケロイド治療の市場規模予測(2019年~2025年)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス(市場動向、機会、成長要因、課題、影響因子)
...
【レポートの概要】

Keloid is an overgrowth of the scar tissues that develop from a wound. Keloid development usually happens after the wound has healed. Keloids grow beyond the border of a scar and develop into a lump. The cause of keloid development cannot be determined but it can develop after surgery, burn injury, piercing, trauma, acne, vaccination and other wounds or cuts. According to the National Institute of Health, keloid scars are commonly seen in people in the age group 10 to 30 years of age.Excision treatment type segment is anticipated to reach a market value of US$ 1,172.1 Mn by 2025 end, expanding at a CAGR of 3.4% during the forecast period.

The global Keloid Treatment market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Keloid Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Keloid Treatment market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Keloid Treatment in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Keloid Treatment manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Novartis
Sensus
RXi
Sonoma
Perrigo
Bristol-Myers Squibb
Pacific World
Valeant
Revitol
Avita

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Occlusive Dressing
Compression Therapy
Cryosurgery
Excision
Radiation Therapy
Laser Therapy
Interferon Therapy
Intralesional Corticosteroid Injection
Others

Segment by Application
Hospitals
Dermatology Clinics
Ambulatory Surgical Centres
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Keloid Treatment
1.1 Definition of Keloid Treatment
1.2 Keloid Treatment Segment by Type
1.2.1 Global Keloid Treatment Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Occlusive Dressing
1.2.3 Compression Therapy
1.2.4 Cryosurgery
1.2.5 Excision
1.2.6 Radiation Therapy
1.2.7 Laser Therapy
1.2.8 Interferon Therapy
1.2.9 Intralesional Corticosteroid Injection
1.2.10 Others
1.3 Keloid Treatment Segment by Applications
1.3.1 Global Keloid Treatment Consumption Comparison by Applications (2014-2025)
1.3.2 Hospitals
1.3.3 Dermatology Clinics
1.3.4 Ambulatory Surgical Centres
1.3.5 Others
1.4 Global Keloid Treatment Overall Market
1.4.1 Global Keloid Treatment Revenue (2014-2025)
1.4.2 Global Keloid Treatment Production (2014-2025)
1.4.3 North America Keloid Treatment Status and Prospect (2014-2025)
1.4.4 Europe Keloid Treatment Status and Prospect (2014-2025)
1.4.5 China Keloid Treatment Status and Prospect (2014-2025)
1.4.6 Japan Keloid Treatment Status and Prospect (2014-2025)
1.4.7 Southeast Asia Keloid Treatment Status and Prospect (2014-2025)
1.4.8 India Keloid Treatment Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Keloid Treatment
2.3 Manufacturing Process Analysis of Keloid Treatment
2.4 Industry Chain Structure of Keloid Treatment

3 Development and Manufacturing Plants Analysis of Keloid Treatment
3.1 Capacity and Commercial Production Date
3.2 Global Keloid Treatment Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Keloid Treatment
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Keloid Treatment Production and Capacity Analysis
4.2 Keloid Treatment Revenue Analysis
4.3 Keloid Treatment Price Analysis
4.4 Market Concentration Degree

5 Keloid Treatment Regional Market Analysis
5.1 Keloid Treatment Production by Regions
5.1.1 Global Keloid Treatment Production by Regions
5.1.2 Global Keloid Treatment Revenue by Regions
5.2 Keloid Treatment Consumption by Regions
5.3 North America Keloid Treatment Market Analysis
5.3.1 North America Keloid Treatment Production
5.3.2 North America Keloid Treatment Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Keloid Treatment Import and Export
5.4 Europe Keloid Treatment Market Analysis
5.4.1 Europe Keloid Treatment Production
5.4.2 Europe Keloid Treatment Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Keloid Treatment Import and Export
5.5 China Keloid Treatment Market Analysis
5.5.1 China Keloid Treatment Production
5.5.2 China Keloid Treatment Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Keloid Treatment Import and Export
5.6 Japan Keloid Treatment Market Analysis
5.6.1 Japan Keloid Treatment Production
5.6.2 Japan Keloid Treatment Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Keloid Treatment Import and Export
5.7 Southeast Asia Keloid Treatment Market Analysis
5.7.1 Southeast Asia Keloid Treatment Production
5.7.2 Southeast Asia Keloid Treatment Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Keloid Treatment Import and Export
5.8 India Keloid Treatment Market Analysis
5.8.1 India Keloid Treatment Production
5.8.2 India Keloid Treatment Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Keloid Treatment Import and Export

6 Keloid Treatment Segment Market Analysis (by Type)
6.1 Global Keloid Treatment Production by Type
6.2 Global Keloid Treatment Revenue by Type
6.3 Keloid Treatment Price by Type

7 Keloid Treatment Segment Market Analysis (by Application)
7.1 Global Keloid Treatment Consumption by Application
7.2 Global Keloid Treatment Consumption Market Share by Application (2014-2019)

8 Keloid Treatment Major Manufacturers Analysis
8.1 Novartis
8.1.1 Novartis Keloid Treatment Production Sites and Area Served
8.1.2 Novartis Product Introduction, Application and Specification
8.1.3 Novartis Keloid Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Sensus
8.2.1 Sensus Keloid Treatment Production Sites and Area Served
8.2.2 Sensus Product Introduction, Application and Specification
8.2.3 Sensus Keloid Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 RXi
8.3.1 RXi Keloid Treatment Production Sites and Area Served
8.3.2 RXi Product Introduction, Application and Specification
8.3.3 RXi Keloid Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Sonoma
8.4.1 Sonoma Keloid Treatment Production Sites and Area Served
8.4.2 Sonoma Product Introduction, Application and Specification
8.4.3 Sonoma Keloid Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Perrigo
8.5.1 Perrigo Keloid Treatment Production Sites and Area Served
8.5.2 Perrigo Product Introduction, Application and Specification
8.5.3 Perrigo Keloid Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Bristol-Myers Squibb
8.6.1 Bristol-Myers Squibb Keloid Treatment Production Sites and Area Served
8.6.2 Bristol-Myers Squibb Product Introduction, Application and Specification
8.6.3 Bristol-Myers Squibb Keloid Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Pacific World
8.7.1 Pacific World Keloid Treatment Production Sites and Area Served
8.7.2 Pacific World Product Introduction, Application and Specification
8.7.3 Pacific World Keloid Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Valeant
8.8.1 Valeant Keloid Treatment Production Sites and Area Served
8.8.2 Valeant Product Introduction, Application and Specification
8.8.3 Valeant Keloid Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Revitol
8.9.1 Revitol Keloid Treatment Production Sites and Area Served
8.9.2 Revitol Product Introduction, Application and Specification
8.9.3 Revitol Keloid Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Avita
8.10.1 Avita Keloid Treatment Production Sites and Area Served
8.10.2 Avita Product Introduction, Application and Specification
8.10.3 Avita Keloid Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served

9 Development Trend of Analysis of Keloid Treatment Market
9.1 Global Keloid Treatment Market Trend Analysis
9.1.1 Global Keloid Treatment Market Size (Volume and Value) Forecast 2019-2025
9.2 Keloid Treatment Regional Market Trend
9.2.1 North America Keloid Treatment Forecast 2019-2025
9.2.2 Europe Keloid Treatment Forecast 2019-2025
9.2.3 China Keloid Treatment Forecast 2019-2025
9.2.4 Japan Keloid Treatment Forecast 2019-2025
9.2.5 Southeast Asia Keloid Treatment Forecast 2019-2025
9.2.6 India Keloid Treatment Forecast 2019-2025
9.3 Keloid Treatment Market Trend (Product Type)
9.4 Keloid Treatment Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Keloid Treatment Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer



【掲載企業】

Novartis、Sensus、RXi、Sonoma、Perrigo、Bristol-Myers Squibb、Pacific World、Valeant、Revitol、Avita

★調査レポート[世界のケロイド治療市場 2019年] (コード:QYR20FB00794)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のケロイド治療市場 2019年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆